Oftalmolosa Cusí (Gentamicin)

Gentamicin, the active ingredient in Oftalmolosa Cusí, is an aminoglycoside antibiotic presented as a unknown strength/unknown form for ophthalmic use. It treats bacterial eye infections and is applied directly to the eye surface in patients who need antimicrobial therapy. GNH USA supplies Oftalmolosa Cusí as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oftalmolosa Cusí as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oftalmolosa Cusí contains gentamicin, an aminoglycoside that acts on bacterial pathogens affecting the eye.

- Bacterial conjunctivitis: reduces bacterial load and alleviates redness and discharge. - Keratitis: helps eradicate the infecting organisms and promotes corneal healing. - Blepharitis: controls bacterial overgrowth on the eyelid margin, decreasing inflammation. - Post‑surgical ocular prophylaxis: lowers the risk of infection after eye surgery. - External ocular surface infections: treats superficial infections of the cornea and conjunctiva.

Gentilec eye drops may introduce local ocular reactions, though most patients tolerate the formulation well.

Common Side Effects: - Burning sensation: mild irritation at the site of instillation. - Redness: transient hyperemia of the conjunctiva. - Tearing: increased lacrimation following application. - Foreign‑body sensation: feeling of grit in the eye. - Itching: mild pruritus of the eyelid margin. - Mild discomfort: temporary stinging.

Serious or Rare Side Effects: - Corneal ulceration: progressive loss of corneal tissue. - Severe allergic reaction: swelling, hives, or anaphylaxis. - Vision loss: sudden decrease in visual acuity. - Ocular toxicity: endothelial cell damage leading to corneal edema. - Persistent pain: ongoing severe ocular discomfort. - Secondary infection: overgrowth of resistant organisms.

When ​​​​​  ​  ​   ​    ...  ....  ...

...